CA Stock MarketDetailed Quotes

EPRX Eupraxia Pharmaceuticals Inc

Watchlist
  • 4.850
  • +0.130+2.75%
15min DelayMarket Closed Dec 13 16:00 ET
172.77MMarket Cap-3.86P/E (TTM)

About Eupraxia Pharmaceuticals Inc Company

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Company Profile

SymbolEPRX
Company NameEupraxia Pharmaceuticals Inc
Founded2011
MarketTSE
Employees29
Fiscal Year Ends12-31
Address201-2067 Cadboro Bay Road
CityVictoria
CountryCAN
Zip Code V8R 5G4
Phone+1 250 590-3968
Websitehttps://www.eupraxiapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. James A. Helliwell, M.D.
  • Chief Executive Officer and Director
  • 517.30K
  • Dr. Amanda Malone
  • Chief Scientific Officer and Chief Operating Officer
  • 368.72K
  • Paul Brennan
  • Chief Business Officer
  • 343.12K
  • Bruce G. Cousins
  • Chief Financial Officer and President
  • 368.72K
  • Dr. Mark Kowalski, M.D.,Pd.D
  • Chief Medical Officer
  • 988.79K
  • Dr. Simon Pione, F.R.C.P.C,M.D.,PhD
  • Chairman of the Board
  • 42.23K
  • Paul L. Geyer, P. Eng.
  • Independent Director
  • 23.56K
  • Dr. Richard M. Glickman,L.L.D.
  • Independent Director
  • 29.86K
  • Dr. Michael Wilmink, M.D.
  • Independent Director
  • 23.56K
  • John S. Montalbano, C.F.A.
  • Independent Director
  • 29.86K
Heat List
CA
Overall
Symbol
Price
% Chg

No Data